282 related articles for article (PubMed ID: 29529087)
1. Implementation of a decentralized community-based treatment program to improve the management of Buruli ulcer in the Ouinhi district of Benin, West Africa.
Amoussouhoui AS; Sopoh GE; Wadagni AC; Johnson RC; Aoulou P; Agbo IE; Houezo JG; Boyer M; Nichter M
PLoS Negl Trop Dis; 2018 Mar; 12(3):e0006291. PubMed ID: 29529087
[TBL] [Abstract][Full Text] [Related]
2. Outcome of Streptomycin-Rifampicin treatment of Buruli Ulcer in two Ghanaian districts.
Iddrisah FN; Yeboah-Manu D; Nortey PA; Nyarko KM; Anim J; Antara SN; Kenu E; Wurapa F; Afari EA
Pan Afr Med J; 2016; 25(Suppl 1):13. PubMed ID: 28149438
[TBL] [Abstract][Full Text] [Related]
3. Clinical outcomes of Ghanaian Buruli ulcer patients who defaulted from antimicrobial therapy.
Klis S; Kingma RA; Tuah W; van der Werf TS; Stienstra Y
Trop Med Int Health; 2016 Sep; 21(9):1191-6. PubMed ID: 27456068
[TBL] [Abstract][Full Text] [Related]
4. The gendered impact of Buruli ulcer on the household production of health and social support networks: Why decentralization favors women.
Agbo IE; Johnson RC; Sopoh GE; Nichter M
PLoS Negl Trop Dis; 2019 Apr; 13(4):e0007317. PubMed ID: 30986205
[TBL] [Abstract][Full Text] [Related]
5. Buruli ulcer in West Africa: strategies for early detection and treatment in the antibiotic era.
Webb BJ; Hauck FR; Houp E; Portaels F
East Afr J Public Health; 2009 Aug; 6(2):144-7. PubMed ID: 20000019
[TBL] [Abstract][Full Text] [Related]
6. Effectiveness of rifampicin-streptomycin for treatment of Buruli ulcer: a systematic review.
Tanywe A; Fernandez RS
JBI Database System Rev Implement Rep; 2017 Jan; 15(1):119-139. PubMed ID: 28085731
[TBL] [Abstract][Full Text] [Related]
7. Decrease in Mycobacterium ulcerans disease (Buruli ulcer) in the Lalo District of Bénin (West Africa).
Anagonou EG; Johnson RC; Barogui YT; Sopoh GE; Ayelo GA; Wadagni AC; Houezo JG; Agossadou DC; Boko M
BMC Infect Dis; 2019 Mar; 19(1):247. PubMed ID: 30871489
[TBL] [Abstract][Full Text] [Related]
8. Response to treatment in a prospective cohort of patients with large ulcerated lesions suspected to be Buruli Ulcer (Mycobacterium ulcerans disease).
Kibadi K; Boelaert M; Fraga AG; Kayinua M; Longatto-Filho A; Minuku JB; Mputu-Yamba JB; Muyembe-Tamfum JJ; Pedrosa J; Roux JJ; Meyers WM; Portaels F
PLoS Negl Trop Dis; 2010 Jul; 4(7):e736. PubMed ID: 20625556
[TBL] [Abstract][Full Text] [Related]
9. Efficacy of the combination rifampin-streptomycin in preventing growth of Mycobacterium ulcerans in early lesions of Buruli ulcer in humans.
Etuaful S; Carbonnelle B; Grosset J; Lucas S; Horsfield C; Phillips R; Evans M; Ofori-Adjei D; Klustse E; Owusu-Boateng J; Amedofu GK; Awuah P; Ampadu E; Amofah G; Asiedu K; Wansbrough-Jones M
Antimicrob Agents Chemother; 2005 Aug; 49(8):3182-6. PubMed ID: 16048922
[TBL] [Abstract][Full Text] [Related]
10. Histopathological changes and clinical responses of Buruli ulcer plaque lesions during chemotherapy: a role for surgical removal of necrotic tissue?
Ruf MT; Sopoh GE; Brun LV; Dossou AD; Barogui YT; Johnson RC; Pluschke G
PLoS Negl Trop Dis; 2011 Sep; 5(9):e1334. PubMed ID: 21980547
[TBL] [Abstract][Full Text] [Related]
11. Chronic wounds in Sierra Leone: Searching for Buruli ulcer, a NTD caused by Mycobacterium ulcerans, at Masanga Hospital.
Please HR; Vas Nunes JH; Patel R; Pluschke G; Tholley M; Ruf MT; Bolton W; Scott JA; Grobusch MP; Bolkan HA; Brown JM; Jayne DG
PLoS Negl Trop Dis; 2021 Oct; 15(10):e0009862. PubMed ID: 34644298
[TBL] [Abstract][Full Text] [Related]
12. An Overview of 10 Years of Activity of a Molecular Laboratory for Buruli Ulcer Diagnosis at a Field Hospital in Benin.
Fajloun F; Ganlonon L; Gnimavo RS; Sodjinou E; Habib A; Claco E; Agoundoté I; Adeye A; Catraye P; Al-Bayssari C; Moussa EH; Robbe-Saule M; Houezo JG; Kpoton GG; Ayélo AG; Gomez B; Johnson RC; Marsollier L; Marion E; Kempf M
J Clin Microbiol; 2023 Jun; 61(6):e0027423. PubMed ID: 37212702
[TBL] [Abstract][Full Text] [Related]
13. Challenges Associated with Management of Buruli Ulcer/Human Immunodeficiency Virus Coinfection in a Treatment Center in Ghana: A Case Series Study.
Tuffour J; Owusu-Mireku E; Ruf MT; Aboagye S; Kpeli G; Akuoku V; Pereko J; Paintsil A; Bonney K; Ampofo W; Pluschke G; Yeboah-Manu D
Am J Trop Med Hyg; 2015 Aug; 93(2):216-23. PubMed ID: 26055745
[TBL] [Abstract][Full Text] [Related]
14. Promising clinical efficacy of streptomycin-rifampin combination for treatment of buruli ulcer (Mycobacterium ulcerans disease).
Chauty A; Ardant MF; Adeye A; Euverte H; Guédénon A; Johnson C; Aubry J; Nuermberger E; Grosset J
Antimicrob Agents Chemother; 2007 Nov; 51(11):4029-35. PubMed ID: 17526760
[TBL] [Abstract][Full Text] [Related]
15. Report of a series of 82 cases of Buruli ulcer from Nigeria treated in Benin, from 2006 to 2016.
Ayelo GA; Anagonou E; Wadagni AC; Barogui YT; Dossou AD; Houezo JG; Aguiar J; Johnson RC; Saizonou R; Asiedu K; Sopoh GE
PLoS Negl Trop Dis; 2018 Mar; 12(3):e0006358. PubMed ID: 29522516
[TBL] [Abstract][Full Text] [Related]
16. Ethnopharmacological reports on anti-Buruli ulcer medicinal plants in three West African countries.
Tsouh Fokou PV; Nyarko AK; Appiah-Opong R; Tchokouaha Yamthe LR; Addo P; Asante IK; Boyom FF
J Ethnopharmacol; 2015 Aug; 172():297-311. PubMed ID: 26099634
[TBL] [Abstract][Full Text] [Related]
17. Rifampicin and clarithromycin (extended release) versus rifampicin and streptomycin for limited Buruli ulcer lesions: a randomised, open-label, non-inferiority phase 3 trial.
Phillips RO; Robert J; Abass KM; Thompson W; Sarfo FS; Wilson T; Sarpong G; Gateau T; Chauty A; Omollo R; Ochieng Otieno M; Egondi TW; Ampadu EO; Agossadou D; Marion E; Ganlonon L; Wansbrough-Jones M; Grosset J; Macdonald JM; Treadwell T; Saunderson P; Paintsil A; Lehman L; Frimpong M; Sarpong NF; Saizonou R; Tiendrebeogo A; Ohene SA; Stienstra Y; Asiedu KB; van der Werf TS;
Lancet; 2020 Apr; 395(10232):1259-1267. PubMed ID: 32171422
[TBL] [Abstract][Full Text] [Related]
18. Antimicrobial treatment for early, limited Mycobacterium ulcerans infection: a randomised controlled trial.
Nienhuis WA; Stienstra Y; Thompson WA; Awuah PC; Abass KM; Tuah W; Awua-Boateng NY; Ampadu EO; Siegmund V; Schouten JP; Adjei O; Bretzel G; van der Werf TS
Lancet; 2010 Feb; 375(9715):664-72. PubMed ID: 20137805
[TBL] [Abstract][Full Text] [Related]
19. Secondary Buruli ulcer skin lesions emerging several months after completion of chemotherapy: paradoxical reaction or evidence for immune protection?
Ruf MT; Chauty A; Adeye A; Ardant MF; Koussemou H; Johnson RC; Pluschke G
PLoS Negl Trop Dis; 2011 Aug; 5(8):e1252. PubMed ID: 21829740
[TBL] [Abstract][Full Text] [Related]
20. Detection of Mycobacterium ulcerans in the environment predicts prevalence of Buruli ulcer in Benin.
Williamson HR; Benbow ME; Campbell LP; Johnson CR; Sopoh G; Barogui Y; Merritt RW; Small PL
PLoS Negl Trop Dis; 2012 Jan; 6(1):e1506. PubMed ID: 22303498
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
